Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
08:03:52 EDT Sat 11 Jul 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:DTCFF - DEFENCE THERAPEUTICS INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
DTCFF - Qnot subscribed0.32346-0.00809-2.41.7030.31705  0.32346  0.317050.7787  0.29214:09:05Jul 0815 min RT 2¢

Recent Trades - All 3 today
Time ETExPriceChangeVolume
14:09:05Q0.32346-0.00809200
10:20:21Q0.31869-0.012861,000
09:46:19Q0.31705-0.0145500
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-07-08 03:16U:DTCFFNews ReleaseDefence Therapeutics Opens New Office in Hamilton to Expand Its Accum Radiopharmaceutical Platform
2026-06-17 03:16U:DTCFFNews ReleaseDefence Therapeutics to Participate in Bio International Convention 2026 Next Week for Strategic Partnership Discussions
2026-06-03 03:16U:DTCFFNews ReleaseDefence Therapeutics Appoints Seasoned Biopharmaceutical Executive Dr John Beaver to Its Board of Directors
2026-06-01 03:16U:DTCFFNews ReleaseDefence Therapeutics Appoints Antibody Drug Conjugates Pioneer Dr. John Lambert to Its Board of Directors
2026-05-29 16:31U:DTCFFNews ReleaseDefence Therapeutics Strengthens Its Scientific Advisory Board with the Appointment of Dr. Sarkis Meterissian
2026-05-19 03:16U:DTCFFNews ReleaseDefence Therapeutics Enhances In-House ADC Development Platform with Expanded Analytical and Cellular Testing Capabilities
2026-04-24 18:31U:DTCFFNews ReleaseDefence Therapeutics Announces Grant of Restricted Stock Units
2026-03-20 18:01U:DTCFFNews ReleaseDefence Therapeutics Announces Warrant Terms Amendment
2026-03-09 03:17U:DTCFFNews ReleaseDefence Therapeutics Announces Closing of Private Placement of Units for Gross Proceeds of $9,595,000
2026-03-02 03:17U:DTCFFNews ReleaseDefence Therapeutics to Showcase Accum Platform at Key International Industry Events in March
2026-02-27 17:01U:DTCFFNews ReleaseDefence Therapeutics Announces Private Placement of Units for Proceeds of up to $11 Million
2026-02-10 03:16U:DTCFFNews ReleaseDefence Therapeutics Aligns Accum ADC Strategy Through Multidisciplinary Scientific Advisory Board
2026-02-04 03:16U:DTCFFNews ReleaseDefence Therapeutics to Present at the World ADC Europe 2026 Showcasing Accum Precision Intracellular Drug-Delivery Platform
2026-01-28 08:41U:DTCFFNews ReleaseDefence Therapeutics Expands Collaboration with Canadian Nuclear Laboratories to Accelerate Its Proprietary Radiopharmaceutical Pipeline
2026-01-21 03:16U:DTCFFNews ReleaseDefence Therapeutics Sharpens Strategic Focus on Precision Drug Delivery to Unlock the Full Potential of Cancer Biologics
2025-12-11 08:35U:DTCFFNews ReleaseDefence Therapeutics to Present at the Life Sciences Virtual Investor Forum December 11th
2025-12-10 16:31U:DTCFFNews ReleaseDefence Therapeutics Announces AGM Results and Provides Corporate Updates
2025-12-04 03:17U:DTCFFNews ReleaseDefence Therapeutics Announces Formation of Scientific Advisory Board to Guide Advancement of Accum-Enhanced Antibody Drug Conjugate Programs
2025-11-21 18:04U:DTCFFNews ReleaseDefence Therapeutics Announces Convertible Debenture Conversion
2025-11-19 03:16U:DTCFFNews ReleaseDefence Therapeutics to Build ADC Drug Delivery Powerhouse Using Its Proprietary Accum Technology